Growth Metrics

Akari Therapeutics (AKTX) Net Cash Flow (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -189.55%
Dec 31, 2025 1,313.84%
Sep 30, 2025 -279.20%
Jun 30, 2025 835.29%
Mar 31, 2025 -156.67%
Dec 31, 2024 101.55%
Sep 30, 2024 -167.38%
Jun 30, 2024 213.40%
Mar 31, 2024 -183.63%
Dec 31, 2023 63.58%
Sep 30, 2023 44.38%
Jun 30, 2023 -163.97%
Jun 30, 2022 -217.18%
Mar 31, 2022 -100.00%
Dec 31, 2021 200.00%
Sep 30, 2021 -13,694,168.55%
Jun 30, 2021 34.41%
Mar 31, 2021 100.00%
Dec 31, 2020 -200.00%
Sep 30, 2020 397.62%
Jun 30, 2020 -200.00%
Mar 31, 2020 310,699,399.07%
Dec 31, 2019 -119.73%
Sep 30, 2019 200.90%
Jun 30, 2019 -993.86%
Mar 31, 2019 109.14%
Dec 31, 2018 15.17%
Sep 30, 2018 39.83%
Jun 30, 2018 -88.36%
Mar 31, 2018 48.36%
Dec 31, 2017 7.56%
Sep 30, 2017 -274.12%
Jun 30, 2017 157.68%
Mar 31, 2017 -132.09%
Dec 31, 2016 818.33%
Sep 30, 2016 92.32%
Jun 30, 2016 -592.50%
Mar 31, 2016 24.03%
Dec 31, 2015 -112.54%
Sep 30, 2015 6,608.95%
Jun 30, 2015 39.34%
Mar 31, 2015 -161.65%
Dec 31, 2014 177.39%
Sep 30, 2014 -68.73%
Jun 30, 2014 -140.03%